The first participant in a clinical trial received an experimental minimally-invasive brain implant to record brain signals, testing the implant’s feasibility for assistive technology. . . . → Read More: Trial Underway Testing Brain-Computer Implant
|
|||||
|
|
A new biotechnology enterprise is developing treatments for aggressive solid tumor cancers that block the effects of DNA residing outside of chromosomes. . . . → Read More: Start-Up Targets Extra DNA in Cancer, Raises $46.4M 
An Indiana company is receiving U.S. government and private grants to develop a solar-powered algorithm-controlled crop dehydrator for small farms. . . . → Read More: Smart Solar Powered Crop Dryer Receives Grant Funds 
Results from a small clinical trial show a treatment for Alzheimer’s disease using radio waves is safe and offers early evidence it can reverse memory loss. . . . → Read More: Trial Shows Radio Waves Safe for Alzheimer’s Therapy 
A high-powered binding protein, formulated as a gel and targeted by Crispr gene editing is shown in lab mice to precisely deliver drugs and kill cancer cells. . . . → Read More: Gel, Crispr Help Defeat Cancer Drug Obstacles 
A chemical engineering team is creating an open network for chemists and data scientists to share data for speeding the development of new molecules. . . . → Read More: A.I.-Powered Network to Identify, Build Molecules 
Results of a small-scale clinical trial show an experimental treatment using an injectable gel to repair damage from a heart attack is safe for patients. . . . → Read More: Hydrogel Shown Safe to Repair Heart Damage 
University and senior care center researchers are building a nationwide network to collect real-world evidence on caring for people with dementia. . . . → Read More: Network to Promote Real-World Dementia Trials 
Apple Inc. plans to release a new medical research app and announced a series of studies for its use in women’s health, hearing, and heart health. . . . → Read More: New App for Medical Research, Studies Revealed 
A two year-old enterprise spun-off from Yale University is developing gene-editing treatments for genetic disorders with synthetic peptides and DNA delivered in nanoscale particles. . . . → Read More: Gene-Editing Biotech Gains $34M in Early Funds |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
